Search Results | Blood | American Society of Hematology

1-20 of 64

Sort by

Sort Order Select

Journal Articles

C1Q labels a highly aggressive macrophage-like leukemia population indicating extramedullary infiltration and relapse

Li-Xue Yang, Cheng-Tao Zhang, Meng-Ying Yang, Xue-Hong Zhang, Hong-Chen Liu, Chen-Hui Luo, Yue Jiang, Zhang-Man Wang, Zhong-Yin Yang, Zhao-Peng Shi, Yi-Ci Yang, Ruo-Qu Wei, Li Zhou, Jun Mi, Ai-Wu Zhou, Zhi-Rong Yao, Li Xia, Jin-Song Yan, Ying Lu

Blood (2023) 141 (7): 766–786.

DOI: https://doi.org/10.1182/blood.2022017046

Published: 2023

Includes: Supplemental data

Journal Articles

Effect of Two Conditionings on Relapse in Myelodysplastic Syndrome and Secondary Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation

Blood (2022) 140 (Supplement 1): 2392.

DOI: https://doi.org/10.1182/blood-2022-158688

Published: 2022

Journal Articles

Machine Learning Algorithm As a Prognostic Tool for Epstein-Barr Virus Reactivation after Haploidentical Hematopoietic Stem Cell Transplantation

Shuang Fan, Hao-Yang Hong, Xin-Yu Dong, Lan-Ping Xu, Xiao-hui Zhang, Yu Wang, Chen-Hua Yan, Huan Chen, Yu-Hong Chen, Wei Han, Fengrong Wang, Jing-Zhi Wang, Kaiyan Liu, Meng-Zhu Shen, Xiao-jun Huang, Shen-Da Hong, Xiao-Dong Mo

Blood (2022) 140 (Supplement 1): 7691–7692.

DOI: https://doi.org/10.1182/blood-2022-165067

Published: 2022

Journal Articles

Efficacy and Safety of MSCs Plus Basiliximab for the Treatment of Steroid-Resistant aGVHD after Haploidentical Stem Cell Transplantation: A Multicenter, Randomized, Open-Label Trial

Blood (2022) 140 (Supplement 1): 4770–4771.

DOI: https://doi.org/10.1182/blood-2022-166307

Published: 2022

Journal Articles

Thrombopoietin Levels Predict the Response to Avatrombopag Treatment in Patients with Persistent Thrombocytopenia after Haploidentical Hematopoietic Stem Cell Transplantation

Haixia Fu, Meng Lv, Yuanyuan Zhang, Tingting Han, Xiao-Dong Mo, Fengrong Wang, Chenhua Yan, Jun Kong, Yu Wang, Yuqian Sun, Wei Han, Huan Chen, Yao Chen, Yu-Hong Chen, Lanping Xu, Kaiyan Liu, Xiaojun Huang, Xiaohui Zhang

Blood (2022) 140 (Supplement 1): 4705–4706.

DOI: https://doi.org/10.1182/blood-2022-166920

Published: 2022

Journal Articles

Preliminary Result of Phase 1 Trial of Orelabrutinib in Combination with Rituximab, Methotrexate, and Dexamethasone in Patients with Newly Diagnosed Primary CNS Lymphoma Implementing Bayesian Design for Dose-Seeking

Yan Yuan, Qian Wang, Dongxiao Zhuang, Tianling Ding, Hong Chen, Fengping Zhu, Kang Zheng, Rui Feng, Jiajun Zheng, Xiaoluo Zhang, Zunguo Du, Ping Zhu, Jinsong Wu, Ying Mao, Tong Chen

Blood (2022) 140 (Supplement 1): 6629–6630.

DOI: https://doi.org/10.1182/blood-2022-159309

Published: 2022

Journal Articles

Real-World Study of the Use of Iguratimod to Treat Chronic/Refractory ITP

Blood (2022) 140 (Supplement 1): 5567–5568.

DOI: https://doi.org/10.1182/blood-2022-167362

Published: 2022

Journal Articles

Basiliximab in the Prevention of aGVHD for Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients with Thalassemia Major: A Prospective, Multicenter, Open-Label, Randomized Controlled Study

Rongrong Liu, Meiqing Wu, Qiaochuan Li, Lianjin Liu, Chunjie Qin, Hong Chen, Lingling Shi, Gaohui Yang, Zeyan Shi, Zhongqing Li, Zhenbin Wei, Beicai Liu, Jing Fan, Yinghua Chen, Xuemei Zhou, Zhongming Zhang, Yongrong Lai, Qifa Liu

Blood (2022) 140 (Supplement 1): 1383–1384.

DOI: https://doi.org/10.1182/blood-2022-166003

Published: 2022

Journal Articles

Patient-Versus Physician-Perceptions of Symptoms, Treatment and Management in Chronic Myeloid Leukemia

Blood (2022) 140 (Supplement 1): 10841–10842.

DOI: https://doi.org/10.1182/blood-2022-157246

Published: 2022

Journal Articles

Single-Cell RNA Profiling of Primary Myelofibrosis Reveals RUX Resistance Decreasing Mononuclear Phagocytes in Peripheral Blood

Luo Dongmei, Na Xu, Xiaoli Liu, Jie Luo, Hanyin Liang, Zherou He, Hong Chen, Qiang Wang, Xuan Zhou

Blood (2022) 140 (Supplement 1): 6755–6756.

DOI: https://doi.org/10.1182/blood-2022-165137

Published: 2022

Journal Articles

An LSC-based MRD assay to complement the traditional MFC method for prediction of AML relapse: a prospective study

Si-Qi Li, Lan-Ping Xu, Yu Wang, Xiao-Hui Zhang, Huan Chen, Yu-Hong Chen, Feng-Rong Wang, Wei Han, Yu-Qian Sun, Chen-Hua Yan, Meng Lv, Fei-Fei Tang, Xiao-Dong Mo, Yan-Rong Liu, Kai-Yan Liu, Ying-Jun Chang, Xiao-Jun Huang

Blood (2022) 140 (5): 516–520.

DOI: https://doi.org/10.1182/blood.2021014604

Published: 2022

Includes: Supplemental data

Journal Articles

Superiority of Leukemic Stem Cell-Based Minimal Residual Disease Assay to Traditional Multiparameter Flow Cytometry-Based Method for Relapse Prediction in AML Patients: A Prospective Study with Randomized Training and Validation Sets

Siqi Li, Lan-Ping Xu, Yu Wang, Xiaohui Zhang, Huan Chen, Yu-Hong Chen, Fengrong Wang, Wei Han, Yuqian Sun, Chenhua Yan, Meng Lyu, Feifei Tang, Xiao-Dong Mo, Kai-Yan Liu, Yingjun Chang, Xiao Jun Huang

Blood (2021) 138 (Supplement 1): 517.

DOI: https://doi.org/10.1182/blood-2021-150011

Published: 2021

Journal Articles

Tacrolimus Plus High-Dose Dexamethasone Versus High-Dose Dexamethasone Alone As First-Line Treatment for Adult Immune Thrombocytopenia: The Phase 2, Open Label, Randomized Trial (TARGET 020)

Blood (2021) 138 (Supplement 1): 13.

DOI: https://doi.org/10.1182/blood-2021-152111

Published: 2021

Journal Articles

Machine-Learning Based Early Warning System for Prediction for Disseminated Intravascular Coagulation after Allogeneic Hematopoietic Stem Cell Transplantation: A Nationwide Multicenter Study

Blood (2021) 138 (Supplement 1): 2113.

DOI: https://doi.org/10.1182/blood-2021-150437

Published: 2021

Journal Articles

Treatment Outcome and Efficacy of Therapeutic Plasma Exchange for Transplant-Associated Thrombotic Microangiopathy in a Real-World Large Cohort Study

Li-Ping Yang, Peng Zhao, Ye-Jun Wu, Hai-Xia Fu, Yun He, Xiao-Dong Mo, Meng Lv, Feng-Rong Wang, Chen-Hua Yan, Yu-Hong Chen, Ying-Jun Chang, Lan-Ping Xu, Kai-Yan Liu, Xiao-Jun Huang, Xiao-Hui Zhang

Blood (2021) 138 (Supplement 1): 1013.

DOI: https://doi.org/10.1182/blood-2021-149373

Published: 2021

Journal Articles

Development and Validation of a Prognostic Model for Transplant-Associated Thrombotic Microangiopathy Following Allogeneic Hematopoietic Stem Cell Transplantation

Blood (2020) 136 (Supplement 1): 16–17.

DOI: https://doi.org/10.1182/blood-2020-138408

Published: 2020

Journal Articles

M1 and M2 Macrophages Play Different Roles in the Pathogenesis of Acute Graft-Versus-Host Disease Post-Allotransplant By Modulating Immune Microenvironment

Qi Wen, MD, Hong-Yan Zhao, PhD, Zhong-Shi Lyu, Yao Weili, Ting-Ting Han, Yu-Hong Chen, Yu Wang, Lan-Ping Xu, Xiao-Hui Zhang, Yuan Kong, Xiao-Jun Huang

Blood (2020) 136 (Supplement 1): 19–20.

DOI: https://doi.org/10.1182/blood-2020-136021

Published: 2020

Journal Articles

Pharmacologic Activation of Aldehyde Metabolism to Protect Hematopoietic Stem Cells (HSC) in Murine Models of Fanconi Anemia (FA)

Jennifer Tsai, MD, Kelsey R. Logas, MS, Lauren D. Van Wassenhove, PhD, Beruh Dejene, BS, Che-Hong Chen, PhD, Daria Mochly-Rosen, PhD, Kenneth I. Weinberg, MD

Blood (2019) 134 (Supplement_1): 105.

DOI: https://doi.org/10.1182/blood-2019-124439

Published: 2019

Journal Articles

Rituximab for Desensitization during HLA-Mismatched Stem Cell Transplantation in Patients with a Positive Donor Specific Anti-HLA Antibody: A Prospective Study

Ying-Jun Chang, Lan-Ping Xu, Yu Wang, Xiao-Hui Zhang, Huan Chen, Yu-Hong Chen, Feng-Rong Wang, Wei Han, Yu-Qian Sun, Chenhua Yan, Fei-Fei Tang, Ming-Rui Huo, Xiao-Dong Mo, MD, Xiang-Yu Zhao, Kai-yan Liu, Xiao-Jun Huang

Blood (2019) 134 (Supplement_1): 5622.

DOI: https://doi.org/10.1182/blood-2019-129781

Published: 2019

Journal Articles

Regulation of the Elevated T Cell Glycolysis May Alleviate Acute Graft-Versus-Host Disease Post-Allotransplant

Qi Wen, MD, Song Yang, Zhong-Shi Lyu, PhD, Wei-Li Yao, Yu-Hong Chen, Ting-Ting Han, Yu Wang, Lan-Ping Xu, Xiao-Hui Zhang, Xiao-Jun Huang, Yuan Kong, MD PhD

Blood (2019) 134 (Supplement_1): 600.

DOI: https://doi.org/10.1182/blood-2019-122795

Published: 2019

NARROW

C1Q labels a highly aggressive macrophage-like leukemia population indicating extramedullary infiltration and relapse

Effect of Two Conditionings on Relapse in Myelodysplastic Syndrome and Secondary Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation

Machine Learning Algorithm As a Prognostic Tool for Epstein-Barr Virus Reactivation after Haploidentical Hematopoietic Stem Cell Transplantation

Efficacy and Safety of MSCs Plus Basiliximab for the Treatment of Steroid-Resistant aGVHD after Haploidentical Stem Cell Transplantation: A Multicenter, Randomized, Open-Label Trial

Thrombopoietin Levels Predict the Response to Avatrombopag Treatment in Patients with Persistent Thrombocytopenia after Haploidentical Hematopoietic Stem Cell Transplantation

Preliminary Result of Phase 1 Trial of Orelabrutinib in Combination with Rituximab, Methotrexate, and Dexamethasone in Patients with Newly Diagnosed Primary CNS Lymphoma Implementing Bayesian Design for Dose-Seeking

Real-World Study of the Use of Iguratimod to Treat Chronic/Refractory ITP

Basiliximab in the Prevention of aGVHD for Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients with Thalassemia Major: A Prospective, Multicenter, Open-Label, Randomized Controlled Study

Patient-Versus Physician-Perceptions of Symptoms, Treatment and Management in Chronic Myeloid Leukemia

Single-Cell RNA Profiling of Primary Myelofibrosis Reveals RUX Resistance Decreasing Mononuclear Phagocytes in Peripheral Blood

An LSC-based MRD assay to complement the traditional MFC method for prediction of AML relapse: a prospective study

Superiority of Leukemic Stem Cell-Based Minimal Residual Disease Assay to Traditional Multiparameter Flow Cytometry-Based Method for Relapse Prediction in AML Patients: A Prospective Study with Randomized Training and Validation Sets

Tacrolimus Plus High-Dose Dexamethasone Versus High-Dose Dexamethasone Alone As First-Line Treatment for Adult Immune Thrombocytopenia: The Phase 2, Open Label, Randomized Trial (TARGET 020)

Machine-Learning Based Early Warning System for Prediction for Disseminated Intravascular Coagulation after Allogeneic Hematopoietic Stem Cell Transplantation: A Nationwide Multicenter Study

Treatment Outcome and Efficacy of Therapeutic Plasma Exchange for Transplant-Associated Thrombotic Microangiopathy in a Real-World Large Cohort Study

Development and Validation of a Prognostic Model for Transplant-Associated Thrombotic Microangiopathy Following Allogeneic Hematopoietic Stem Cell Transplantation

M1 and M2 Macrophages Play Different Roles in the Pathogenesis of Acute Graft-Versus-Host Disease Post-Allotransplant By Modulating Immune Microenvironment

Pharmacologic Activation of Aldehyde Metabolism to Protect Hematopoietic Stem Cells (HSC) in Murine Models of Fanconi Anemia (FA)

Rituximab for Desensitization during HLA-Mismatched Stem Cell Transplantation in Patients with a Positive Donor Specific Anti-HLA Antibody: A Prospective Study

Regulation of the Elevated T Cell Glycolysis May Alleviate Acute Graft-Versus-Host Disease Post-Allotransplant

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only